Flu cases are on the rise, and the reason is clear: vaccine eligibility has expanded to those over 50. This shift in eligibility reflects a growing body of evidence that mid-life individuals face heightened risks from influenza. The data is alarming: since January, over 2,630 flu cases have been recorded among those aged 50 to 64, and in 2025, over 27% of all flu cases occurred in adults aged 50 and over. This trend is particularly concerning, as only about one-third of people in this age group were vaccinated last year. The implications are dire: annually, influenza causes over 13,500 hospitalisations and over 3,000 deaths among adults aged 50 and over in Australia. Public Health Physician and GP Professor Paul Van Buynder underscores the heightened risk, stating that the immune system changes with age, even if lifestyle hasn't. Catching the flu can lead to hospitalisation or worse, making vaccination crucial. Research supports this, showing that immune function declines with age, while chronic conditions like diabetes, cardiovascular disease, and respiratory illness increase the likelihood of severe influenza outcomes. Moreover, vaccine responses may be less effective in older adults. Patients Australia’s Dr Nick Coatsworth highlights the underestimation of influenza's impact by those in their 50s. He emphasises that 'just the flu' can be a serious illness, causing weeks of illness and missed work and social time. The data bears this out: only about one in three Australians aged 50-64 received a flu vaccine last year, compared to almost two-thirds of those aged 65 and over. Pharmacies and health providers are proactively offering vaccinations ahead of the winter peak, with protection taking up to two weeks to become effective. Health authorities recommend annual vaccination due to the evolving influenza strains. TerryWhite Chemmart's Deputy Chief Pharmacist, Kate Gunthorpe, warns of the potential impact of influenza, noting that last year's season was significant and widespread, with over half a million confirmed cases placing pressure on families and the healthcare system. Gunthorpe emphasises that vaccination remains the simplest and most effective way to reduce risk. Influenza vaccination is recommended for everyone aged six months and over, with free vaccines available under the National Immunisation Program for higher-risk groups, including young children, pregnant women, people aged 65 and over, Aboriginal and Torres Strait Islander people, and those with certain medical conditions. The expansion of access to Fluad is a positive step, according to CSL Seqirus Vaccines Medical Director, Dr Jules Bayliss, who notes that reducing the impact of flu on families, communities, and the health system is a mission for the company. Health experts advise Australians, especially those aged 50 and over, to consult their GP or pharmacist about vaccination options as the 2026 flu season approaches. However, it's crucial to remember that this article is for general information only and should not be considered personalised health advice. Before making health-related decisions, individuals should assess their personal health requirements and seek professional medical advice.
